Tianjing Bio is included in the MSCI China Index

Tianjing Biotech announced that Tianjing Bio will be included in the MSCI China All Shares Index (MSCI China All Shares Index) constituent stocks, which will take effect after the market closes on May 27, 2021
.

The MSCI China Index is compiled by the world-renowned index compiling company MSCI, and is compiled based on the comprehensive Chinese stocks in the MSCI International Emerging Market Index.
It provides a representative sample of the entire Chinese stock investment range, and aims to track H shares, The performance of large and medium-sized shares including A shares, B shares, red chips, P shares and overseas listed companies (such as American Depositary Receipts)
.

Mr.
Zhu Jielun, Chief Financial Officer of Tianjing Biotech, said: "The successful entry into the MSCI industry benchmark index is another important capital market milestone reached by Tianjing Biotech after being included in the Nasdaq Biotechnology Index in December 2020.
At the same time, it also fully demonstrates the increasing popularity and influence of Tianjing Biological among global investors
.